Development, validation and prospective clinical implementation of a machine learning algorithm for incident cardio-renal-metabolic diseases and cardiovascular death: the OPTIMISE study.

25 April 2024 (09:00 - 12:30)

Organised by:

Sign in to view the resources

Sign in to view the resources

Sign in to view the resources

About the speaker

Doctor Ramesh Nadarajah

Leeds General Infirmary, Leeds (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Early insulin resistance in low-risk subjects with normal glycemia is associated with subclinical atherosclerosis

Doctor J. Iglesies-Grau (Montreal, CA)

Abstract Slides Video

Presentation thumbnail

Cholesterol paradox in atrial fibrillation: is it solved in lipid-lowering drugs users?

Doctor B. Bartos (Olsztyn, PL)

Abstract Slides Video

Presentation thumbnail

Comparative effectiveness of non-pharmacological interventions on metabolic syndrome and its components: a systematic review and network meta-analysis

Ms B. Chan (Hong Kong, HK)

Abstract Slides Video

Presentation thumbnail

Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort.

Doctor C. Luz Goulart (Porto Alegre, BR)

Abstract Slides Video

Access the full session

Session thumbnail

Young Investigator Award - Primary Care & Risk Factor Management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Saving hearts, extending lives: the impact of risk prevention on lifetime estimates in Germany

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources